Antifungal activity of low molecular weight chitosan against clinical isolates ofCandidaspp.
Open Access
- 1 December 2010
- journal article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 48 (8), 1018-1023
- https://doi.org/10.3109/13693786.2010.486412
Abstract
Chitosan is a natural polymer derived from chitin, a structural component of fungi, insects and shrimp, which exerts antimicrobial effects against bacteria and fungi. The aim of this study was to investigate the in vitro antifungal activity of low molecular weight chitosan (LMWC), and the potential synergy between chitosan and a currently used antifungal drug, fluconazole. The in vitro minimal inhibitory concentrations (MICs) of chitosan and fluconazole against 105 clinical Candida isolates were measured by the broth microdilution method. LMWC exhibited a significant antifungal activity, inhibiting over 89.9% of the clinical isolates examined (68.6% of which was completely inhibited). The species included several fluconazole-resistant strains and less susceptible species such as C. glabrata, which was inhibited at a concentration of 4.8 mg/l LMWC. Although some strains were susceptible at pH 7.0, a greater antifungal activity of LMWC was observed at pH 4.0. There was no evidence of a synergistic effect of the combination of LMWC and fluconazole at pH 7.0. This is the first report in which the antifungal activity of LMWC was investigated with clinical Candida strains. The use of LMWC as an antifungal compound opens new therapeutic perspectives, as the low toxicity of LMWC in humans supports its use in new applications in an environment of pH 4.0–4.5, such as a topical agent for vulvovaginal candidiasis.Keywords
This publication has 25 references indexed in Scilit:
- A novel cell‐adhesive scaffold material for delivering keratinocytes reduces granulation tissue in dermal woundsWound Repair and Regeneration, 2009
- Recent Advances in Drugs and Prodrugs Design of ChitosanCurrent Pharmaceutical Design, 2008
- Chitosan composite films. Biomedical applicationsJournal of Materials Science: Materials in Medicine, 2007
- An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factorBurns, 2006
- Chitosan as Antimicrobial Agent: Applications and Mode of ActionBiomacromolecules, 2003
- Antimicrobial Activity of Native Chitosan, Degraded Chitosan, and O-Carboxymethylated ChitosanJournal of Food Protection, 2003
- Topical formulations and wound healing applications of chitosanAdvanced Drug Delivery Reviews, 2001
- Antimicrobial Actions of Degraded and Native Chitosan against Spoilage Organisms in Laboratory Media and FoodsApplied and Environmental Microbiology, 2000
- Decrease in serum LDL cholesterol with microcrystalline chitosanMethods and Findings in Experimental and Clinical Pharmacology, 1999
- Chitosan: Effects on Wound Healing in Urogenital Tissue: Preliminary ReportJournal of Urology, 1988